Cargando…

Clinicopathological characteristics and prognostic analysis of breast cancer with a hormone receptor status of ER(-)/PR(+)

BACKGROUND: It is unknown whether ER(-)/PR(+) breast cancer is an independent breast cancer subtype, how it differs from other subtypes, and what its significance is regarding treatment and prognosis. This study compared ER(-)/PR(+) breast cancer with other subtypes to better understand the biologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xinli, Xue, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394835/ https://www.ncbi.nlm.nih.gov/pubmed/37538790 http://dx.doi.org/10.3389/fendo.2023.1193592

Ejemplares similares

Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer
por: You, Shuhui, et al.
Publicado: (2023)

Editorial: Hormone Receptors and Breast Cancer
por: Brunetti, Antonio, et al.
Publicado: (2019)

Editorial: Hormones and receptors in breast cancer
por: Rosemblit, Cinthia, et al.
Publicado: (2023)

Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?
por: Chatterjee, Sanjoy, et al.
Publicado: (2015)

Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
por: Reinert, Tomás, et al.
Publicado: (2022)

The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer
por: Huang, Weisun, et al.
Publicado: (2016)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Editorial: Steroid hormone receptors and cell cycle in breast cancer
por: Fabris, Victoria T., et al.
Publicado: (2023)

ODP433 An increased in AIPB expression in Triple Negative (ER-/PR-/Her2-) Breast Tumors reduces estradiol synthesis
por: Downs, William V, et al.
Publicado: (2022)

SCM-198 Prevents Endometriosis by Reversing Low Autophagy of Endometrial Stromal Cell via Balancing ERα and PR Signals
por: Lin, Yi-Kong, et al.
Publicado: (2022)

Steroid hormone receptors ERα and PR characterised by immunohistochemistry in the mare adrenal gland
por: Alm, Ylva Hedberg, et al.
Publicado: (2009)

Clinicopathological features and prognosis of male breast cancer
por: Wang, Xinli, et al.
Publicado: (2021)

Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study
por: Hussein, Israa A, et al.
Publicado: (2020)

Shared sex hormone metabolism-related gene prognostic index between breast and endometrial cancers
por: Duan, Junyi, et al.
Publicado: (2023)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

Clinicopathological Characteristics and Breast Cancer–Specific Survival of Patients With Single Hormone Receptor–Positive Breast Cancer
por: Li, Yunhai, et al.
Publicado: (2020)

Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves’ orbitopathy
por: Park, Jungyul, et al.
Publicado: (2023)

Interfering Role of ERα on Adiponectin Action in Breast Cancer
por: Naimo, Giuseppina Daniela, et al.
Publicado: (2020)

The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
por: Yuan, Jie, et al.
Publicado: (2023)

Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
por: Mao, Jinqian, et al.
Publicado: (2021)

The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
por: Zhang, Ailin, et al.
Publicado: (2021)

Gonadotropin Inhibitory Hormone and Its Receptor: Potential Key to the Integration and Coordination of Metabolic Status and Reproduction
por: Bédécarrats, Grégoy Y., et al.
Publicado: (2022)

Prolactin: The Third Hormone in Breast Cancer
por: Schuler, Linda A., et al.
Publicado: (2022)

Clinicopathologic Characteristics and Outcomes of Massive Multinodular Goiter: A Retrospective Cohort Study
por: Chen, Qiang, et al.
Publicado: (2022)

Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2022)

Involvement of Membrane Progestin Receptor Beta (mPRβ/Paqr8) in Sex Pheromone Progestin-Induced Expression of Luteinizing Hormone in the Pituitary of Male Chinese Black Sleeper (Bostrychus Sinensis)
por: Zhang, Yu Ting, et al.
Publicado: (2018)

The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone
por: Campbell, Esther J, et al.
Publicado: (2016)

Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance
por: Bernardo, Carina, et al.
Publicado: (2021)

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
por: Dubrava, Alex L, et al.
Publicado: (2023)

Genetic and clinical landscape of ER + /PR- breast cancer in China
por: Dai, Danian, et al.
Publicado: (2023)

(Thyroid) Hormonal regulation of breast cancer cells
por: Hercbergs, Aleck, et al.
Publicado: (2023)

Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer
por: Aesoy, Reidun, et al.
Publicado: (2015)

Proteomic Analysis of the Intestinal Resistance to Thyroid Hormone Mouse Model With Thyroid Hormone Receptor Alpha Mutations
por: Xi, Yue, et al.
Publicado: (2022)

Unique ER PR expression pattern in breast cancers with CHEK2 mutation: a hormone receptor and HER2 analysis based on germline cancer predisposition genes
por: Wei, Grace, et al.
Publicado: (2022)

The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis
por: Meng, Yu-Fan, et al.
Publicado: (2023)

Choosing the right partner in hormone-dependent gene regulation: Glucocorticoid and progesterone receptors crosstalk in breast cancer cells
por: Pecci, Adali, et al.
Publicado: (2022)

The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells
por: Szmyd, Monica, et al.
Publicado: (2018)

Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer
por: Li, Xingchen, et al.
Publicado: (2021)

Growth Hormone Receptor Regulation in Cancer and Chronic Diseases
por: Strous, Ger J., et al.
Publicado: (2020)

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease
por: Hilton, Heidi N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ultp8m4rt7g6dfc82cg3p0d45d